Share This

Related Topics News - Drugs

     
 < Previous page   Detail   |   Print    Next page > 
     
《大行》大摩降白雲山目標價至21.4元 下調盈測
2024-12-24T  
上海:加快推進證券公司合併 設百億人幣生物醫藥產業併購基金
2024-12-10T  
威高股份獲世銀集團成員及國金公司2.5億美元七年期貸款融資
2024-12-08T  
康哲藥業獲1類新藥ABP-671獨家商業化權利
2024-12-02T  
《業績》精優藥業中期純利1.01億元 虧轉盈
2024-12-01T  
白雲山附屬以逾5.2億人民幣向興證資管應收賬款
2024-11-28T  
國家醫保局:協議期內談判藥品累計為患者減負逾8,800億人幣
2024-11-28T  
新版國家醫保藥品目錄新增91種藥品 預計明年為患者減負逾500億人幣
2024-11-28T  
康哲藥業創新藥CMS-D005獲准開展臨床試驗
2024-11-28T  
粵港澳大灣區國際臨床試驗所開幕
2024-11-21T  
 < Previous page    Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.